89bio, Inc

$24.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (+2.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell 89bio, Inc and other stocks, options, and ETFs commission-free!

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases.

CEO
Rohan Palekar
Employees
27
Headquarters
San Francisco, California
Founded
2018
Market Cap
480.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.98K
High Today
$24.86
Low Today
$23.91
Open Price
$24.31
Volume
128.50K
52 Week High
$42.36
52 Week Low
$18.01

ETNB Earnings

-$30.63
-$20.42
-$10.21
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, After Hours

You May Also Like

CHPT+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure